Our asset pipeline
We’re proud of the extensive pipeline in clinical and preclinical development we have built with both our partners and internal discovery programs.
Isogenica’s partnerships with global biopharmaceutical companies and leading research institutions have resulted in a deep pipeline including two assets in clinical development and nine partnered pre-clinical assets in addition to our own internal research programs.
Partnerships at Isogenica
Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including one clinical Phase II asset and eleven partnered pre-clinical and discovery programs.